Skip to content

Robotic Exoskeleton Gait Training During Acute Stroke Rehabilitation

Robotic Exoskeleton Gait Training During Acute Stroke Rehabilitation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04775693
Acronym
RERC
Enrollment
96
Registered
2021-03-01
Start date
2017-05-12
Completion date
2022-12-31
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Keywords

hemiplegia, robotic, exoskeleton, gait

Brief summary

The objective of this RCT is to explore the clinical, functional and neurophysiological effectiveness of RE-assisted (Robotic Exoskeleton) early intervention gait therapy in stroke patients during inpatient and outpatient stroke rehabilitation as compared to traditional gait training in three groups: 1) RE; 2) RE-Standard of Care (SOC) and 3) SOC. We will evaluate the short and long-term effects on functional mobility, clinical, neurophysiological, community participation and quality of life.

Interventions

DEVICERE (Robotic Exoskeleton)

Participants will continue to receive their prescribed standard of care physical therapy/gait training. They will also utilize the robotic exoskeleton twice a week during their inpatient stay and 3 times a week for 5 weeks as an outpatient (for outpatient, only if in the RE group). The Robotic Exoskeleton is a device that will be strapped to the chest and legs and worn over the shoulders like a backpack that will assist in walking. It uses sensors and participant motion to move. A licensed physical therapist will be assisting participants as they use the device.

Traditional physical therapist driven gait training.

Sponsors

Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Stroke survivors \< 4 weeks from most recent stroke. * Age: 21- 80 years * Unilateral hemiparesis * Medical clearance by a Kessler Institute for Rehabilitation physician. * Be able to physically fit into the exoskeleton device. * Be able to tolerate upright standing for 30 minutes. * Have joint range of motion within normal functional limits for ambulation. * Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE. * Have stable blood pressure; no diagnosis of persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in body weight support system). * Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation, e.g. can follow directions as determined by a Kessler Institute for Rehabilitation physician or physical therapist. * No history of injury or pathology to the unaffected limb.

Exclusion criteria

* Unable to physically fit within the RE: Height below 60 or above 76 and weight above 220 lbs. * Joint contracture or spasticity of any limb that limits normal ROM during ambulation with assistive devices. * Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity). * Skin issues that would prevent wearing the device. * Pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance. * Pre-existing condition that caused exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure) * Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study. * Severe cognitive or psychiatric problems as well as incontinence might be contraindications to start training with a RE. * History of severe cardiac disease such as myocardial infarction, congestive heart failure. * Uncontrolled seizure disorder. * Uncontrolled spasticity that would interfere with walking in the RENeuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or traumatic brain injury with evidence of motor weakness and multiple sclerosis) that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs * Orthopedic pathologies or history that will interfere with ambulation or limit the range of motion of the lower limbs (e.g., knee replacement, fixed contractures, inflammation) * Pregnant as confirmed by pregnancy test.

Design outcomes

Primary

MeasureTime frameDescription
TUG6 monthstime up and go (TUG) test
BBA6 monthsBerg Balance Assessment (BBA)
ROM6 monthsrange of motion (ROM)- conventional assessment performed by a physical therapist
strength6 monthsconventional assessment performed by a physical therapist
temporal spatial parameters6 monthscollected though motion capture camera system
plantar loading6 monthsuse of shoe insoles to gather information about foot pressure
electromyography (EMG)6 monthsa measure of muscle activation (EMG signal) at different phases of gait cycle (swing versus double support).
SIS6 monthsstroke impact scale (SIS). questionnaire about quality of life post-stroke
Functional Independence Measure (FIM)6 monthsa conventional assessment measure of motor function
LIFE-H6 monthsassessment of life habits (LIFE-H). questionnaire about quality of life post-stroke
SSQoL6 monthsstroke specific quality of life scale (SSQoL). questionnaire about quality of life post-stroke

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026